Sanofi Hits Merck With Patent Suit Over New Diabetes Drug
French pharmaceutical giant Sanofi-Aventis US Inc. sued Merck & Co. Inc.'s overseas unit in Delaware federal court Friday, alleging the rival pharmaceutical company developed a diabetes drug that infringes 10 patents...To view the full article, register now.
Already a subscriber? Click here to view full article